Gladstone NOW: The Campaign Join Us on the Journey ✕
31 - 45 of 116 Results Clear All
The findings could point toward new ways to prevent or treat one of the most common birth defects
News Release Research (Publication) Congenital Heart Disease Cardiovascular Disease Bruneau Lab Human Genetics Stem Cells/iPSCs
A drug candidate found by Gladstone researchers could help prevent tens of thousands of heart surgeries every year
News Release Research (Publication) Heart Failure Cardiovascular Disease Srivastava Lab Theodoris Lab AI CRISPR/Gene Editing Disease Models Stem Cells/iPSCs
USA Today—California Proposition 14 put funding for the Stem Cell Research Institute on the ballot this year. Gladstone President Deepak Srivastava, MD, explains how previous funding for stem cell research in California has helped bring the field to a point where stem cell–based therapies are now possible.
Gladstone Experts Cardiovascular Disease Srivastava Lab Stem Cells/iPSCs
abc News—In 2019, the Trump administration suspended federal funding for research involving fetal tissue. Gladstone President Deepak Srivastava explains that if the funding ban had been in place over the last few decades, many important drugs—including treatments for COVID-19—would not have been developed.
Gladstone Experts COVID-19 Roddenberry Stem Cell Center Srivastava Lab Stem Cells/iPSCs
ABC7 News—While some COVID-19 cases are severe and cause rapid decline, other patients experience only mild symptoms. Gladstone President Deepak Srivastava explains how stem cell research could help explain this phenomenon, and lead to targeted treatments.
Research (Publication) COVID-19 Stem Cells/iPSCs
The Stem Cell Podcast—Gladstone President Deepak Srivastava describes his work using human induced pluripotent stem cells to investigate the gene networks that dictate cell fate decisions, and how this research could lead to therapeutics for congenital heart disease and heart failure. He also describes the importance of stem cell research in fighting the COVID-19 pandemic.
Gladstone Experts COVID-19 Heart Failure Congenital Heart Disease Cardiovascular Disease Roddenberry Stem Cell Center Srivastava Lab Stem Cells/iPSCs
Gladstone researcher Alex Pico helped develop a new way to measure the difference one discovery can make on science around the world.
Research (Publication) Bioinformatics Core Data Science and Biotechnology Big Data Stem Cells/iPSCs
The Stem Cell Podcast—Gladstone Senior Investigator Todd McDevitt describes his work using stem cells to understand how tissues grow and organize themselves, and how these efforts lay the groundwork for regenerative medicine therapies.
Gladstone Experts Heart Failure Cardiovascular Disease McDevitt Lab Organoids Stem Cells/iPSCs
The Center for iPS Cell Research and Application (CiRA) at Kyoto University opened a new on-site laboratory at Gladstone Institutes.
Institutional News iPS Cell Research Center Yamanaka Lab Stem Cells/iPSCs
Gladstone researchers used a machine-learning approach to discover new ways of controlling the spatial organization of induced pluripotent stem cells.
News Release Research (Publication) Histology and Light Microscopy Core Stem Cell Core Conklin Lab McDevitt Lab AI Big Data CRISPR/Gene Editing Imaging
New study shows how patterns in brain activity can be an early predictor of Alzheimer’s symptoms.
News Release Research (Publication) Behavioral Core Alzheimer’s Disease Dementia Center for Systems and Therapeutics Neurological Disease Huang Lab Stem Cells/iPSCs
Gordon Keller, recipient of the 2019 Ogawa-Yamanaka Stem Cell Prize, discusses challenges and successes during his 30 years of pioneering research on stem cells.
Ogawa Stem Cell Prize Profile Roddenberry Stem Cell Center Stem Cells/iPSCs
These tiny versions of the heart, brain, intestine, lungs, and other organs are transforming how we research human disease and development at Gladstone and beyond.
Research (Publication) Spinal Cord Injuries Cardiovascular Disease Data Science and Biotechnology Virology Conklin Lab Greene Lab McDevitt Lab Ott Lab AI
Since Shinya Yamanaka discovered a method to create human induced pluripotent stem (iPS) cells, Gladstone researchers have built on this technology to create numerous iPS cell lines, coax iPS cells into a myriad of tissue types, use them as a tool to study disease, and even begin creating therapies using these cells.
Research (Publication) Stem Cell Core Huntington’s Disease Alzheimer’s Disease Finkbeiner Lab Huang Lab McDevitt Lab Srivastava Lab Yamanaka Lab CRISPR/Gene Editing
Keller’s work with pluripotent stem cells has led to a platform for disease modeling and regenerative medicine
Awards Institutional News News Release Ogawa Stem Cell Prize Stem Cells/iPSCs
